In 2024, the forecast for the total number of top-cited scientific publications in drug discovery in France stands at 13.7 publications. This figure shows a declining trend over the subsequent years, dropping to 11.66 publications by 2028. The compound annual growth rate (CAGR) over this period is negative, indicating a steady decrease year-on-year.

From 2023, when the figure was higher, the ongoing downward trend reflects challenges in maintaining a high impact in scientific research output. The year-on-year variations reveal a consistent decline, which might be influenced by funding, research focus shifts, or international competition.

Future trends to watch for include: